Bill Commons

CA AB 536

in committee

Health care coverage: colorectal cancer screening.

California · 2025-2026 Regular Session · lower

Quick answers

Did CA AB 536 pass?

Not yet. CA AB 536 is in committee as of 2025-08-29 and has not come to a final vote. Latest recorded action (2025-08-29): In committee: Held under submission.

What is CA AB 536 about?

Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally requires a health care service plan contract or a health insurance policy issued, amended, or renewed on or after January 1, 2022, to provide coverage without cost sharing for a colorectal cancer screening test assigned either a grade of A or a grade of B by the United States Preventive Services Task Force and for a required colonoscopy for a positive result on a test with those grades. This bill would additionally require that coverage if the screening test is approved by the United States Food and Drug Administration and either meets requirements for coverage established by the federal Centers for Medicare and Medicaid Services, as specified, or is included in the most recently published guidelines from the American Cancer Society.

Who sponsors CA AB 536?

Patterson is the primary sponsor of CA AB 536.

Description

Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law generally requires a health care service plan contract or a health insurance policy issued, amended, or renewed on or after January 1, 2022, to provide coverage without cost sharing for a colorectal cancer screening test assigned either a grade of A or a grade of B by the United States Preventive Services Task Force and for a required colonoscopy for a positive result on a test with those grades. This bill would additionally require that coverage if the screening test is approved by the United States Food and Drug Administration and either meets requirements for coverage established by the federal Centers for Medicare and Medicaid Services, as specified, or is included in the most recently published guidelines from the American Cancer Society.

Introduced
2025-03-24
Latest action
2025-08-29 — In committee: Held under submission.
Bill type
bill
Last updated

Subjects

Sponsors

  • Pattersonauthor

Committees

Not provided by source.

Action timeline

  1. 2025-02-11

    Read first time. To print.

    reading-1

  2. 2025-02-12

    From printer. May be heard in committee March 14.

  3. 2025-03-24

    Referred to Com. on HEALTH.

    referral-committee

  4. 2025-03-24

    From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  5. 2025-03-25

    Re-referred to Com. on HEALTH.

    referral-committee

  6. 2025-04-09

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 15. Noes 0.) (April 8). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  7. 2025-04-23

    From committee: Do pass. (Ayes 15. Noes 0.) (April 23).

    committee-passage,committee-passage-favorable

  8. 2025-04-24

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  9. 2025-05-05

    Read third time. Passed. Ordered to the Senate. (Ayes 74. Noes 0. Page 1425.)

    passage,reading-1,reading-3

  10. 2025-05-06

    In Senate. Read first time. To Com. on RLS. for assignment.

    reading-1,referral-committee

  11. 2025-05-14

    Referred to Com. on HEALTH.

    referral-committee

  12. 2025-06-11

    In committee: Set, first hearing. Hearing canceled at the request of author.

  13. 2025-06-26

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 1.) (June 25). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  14. 2025-07-14

    In committee: Referred to APPR. suspense file.

    referral-committee

  15. 2025-08-29

    In committee: Held under submission.

Versions

Documents

Votes

  • Do pass and be re-referred to the Committee on [Appropriations]

    2025-04-08 · pass · 15-0

    Member-level votes (15)
    • Sharp-Collins: yes
    • Celeste Rodriguez: yes
    • Krell: yes
    • Mark González: yes
    • Arambula: yes
    • Carrillo: yes
    • Patel: yes
    • Schiavo: yes
    • Stefani: yes
    • Sanchez: yes
    • Chen: yes
    • Aguiar-Curry: yes
    • Flora: yes
    • Addis: yes
    • Bonta: yes
  • Do pass.

    2025-04-23 · pass · 15-0

    Member-level votes (15)
    • Pacheco: yes
    • Ta: yes
    • Arambula: yes
    • Wicks: yes
    • Hart: yes
    • Solache: yes
    • Pellerin: yes
    • Mark González: yes
    • Calderon: yes
    • Fong: yes
    • Sanchez: yes
    • Caloza: yes
    • Tangipa: yes
    • Elhawary: yes
    • Dixon: yes
  • AB 536 Patterson Assembly Third Reading

    2025-05-05 · pass · 74-0

    Member-level votes (79)
    • Rivas: yes
    • Haney: yes
    • Papan: yes
    • Wallis: yes
    • Jackson: yes
    • Caloza: yes
    • Lackey: yes
    • Patel: yes
    • Schultz: yes
    • Wicks: yes
    • Irwin: yes
    • Pacheco: yes
    • Zbur: yes
    • Fong: yes
    • Macedo: yes
    • Ransom: yes
    • Petrie-Norris: yes
    • Boerner: yes
    • Hoover: yes
    • Krell: yes
    • Celeste Rodriguez: yes
    • Lowenthal: yes
    • Mark González: yes
    • Soria: yes
    • Ta: yes
    • Ávila Farías: yes
    • Bonta: yes
    • Alvarez: yes
    • DeMaio: yes
    • Kalra: yes
    • Addis: yes
    • Dixon: yes
    • Muratsuchi: yes
    • Sharp-Collins: yes
    • Solache: yes
    • Rogers: yes
    • McKinnor: yes
    • Alanis: yes
    • Connolly: yes
    • Castillo: yes
    • Bauer-Kahan: yes
    • Carrillo: yes
    • Gallagher: yes
    • Valencia: yes
    • Elhawary: yes
    • Hadwick: yes
    • Jeff Gonzalez: yes
    • Nguyen: yes
    • Chen: yes
    • Bennett: yes
    • Sanchez: yes
    • Quirk-Silva: yes
    • Calderon: yes
    • Blanca Rubio: yes
    • Harabedian: yes
    • Hart: yes
    • Stefani: yes
    • Bryan: yes
    • Davies: yes
    • Gabriel: yes
    • Ortega: yes
    • Patterson: yes
    • Ramos: yes
    • Ward: yes
    • Tangipa: yes
    • Wilson: yes
    • Schiavo: yes
    • Pellerin: yes
    • Gipson: yes
    • Aguiar-Curry: yes
    • Arambula: yes
    • Ahrens: yes
    • Berman: yes
    • Flora: yes
    • Michelle Rodriguez: other
    • Garcia: other
    • Bains: other
    • Lee: other
    • Ellis: other
  • Do pass, but first be re-referred to the Committee on [Appropriations]

    2025-06-25 · pass · 8-1

    Member-level votes (11)
    • Grove: yes
    • Rubio: yes
    • Richardson: yes
    • Wiener: yes
    • Gonzalez: yes
    • Valladares: yes
    • Padilla: yes
    • Limón: yes
    • Weber Pierson: no
    • Menjivar: other
    • Durazo: other
  • Placed on suspense file

    2025-07-14 · pass · 7-0

    Member-level votes (7)
    • Cabaldon: yes
    • Wahab: yes
    • Richardson: yes
    • Dahle: yes
    • Grayson: yes
    • Caballero: yes
    • Seyarto: yes

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 536. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.